{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:49:25Z","timestamp":1790660965383,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T00:00:00Z","timestamp":1647475200000},"content-version":"am","delay-in-days":381,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.bulcan.2020.11.014","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T16:42:18Z","timestamp":1613580138000},"page":"295-303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Condition de r\u00e9alisation de la cytaph\u00e9r\u00e8se pour la mise \u00e0 disposition du mat\u00e9riel biologique n\u00e9cessaire \u00e0 la production de CAR T-cells commerciaux\u00a0: avis d\u2019experts propos\u00e9 par la SFGM-TC"],"prefix":"10.1016","volume":"108","author":[{"given":"Sylvie","family":"Carnoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Beaumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarik","family":"Kanouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Parquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Beauvais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Hequet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justina","family":"Kanold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Ballot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Mialou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Reppel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gandhi","family":"Damaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Yakoub-Agha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Chabannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bulcan.2020.11.014_bib0115","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/0006-291X(87)90502-X","article-title":"Expression of chimeric receptor composed of immunoglobulin-derived V regions and T-cell receptor-derived C regions","volume":"149","author":"Kuwana","year":"1987","journal-title":"Biochem Biophys Res Commun"},{"issue":"24","key":"10.1016\/j.bulcan.2020.11.014_bib0120","doi-asserted-by":"crossref","first-page":"10024","DOI":"10.1073\/pnas.86.24.10024","article-title":"Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity","volume":"86","author":"Gross","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.bulcan.2020.11.014_bib0125","first-page":"35","article-title":"CAR T-cells: a John von Neumann legacy?","volume":"66","author":"Quesnel","year":"2018","journal-title":"Curr Res Transl Med"},{"issue":"4","key":"10.1016\/j.bulcan.2020.11.014_bib0130","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1158\/2159-8290.CD-12-0548","article-title":"The basic principles of chimeric antigen receptor design","volume":"3","author":"Sadelain","year":"2013","journal-title":"Cancer Discov"},{"issue":"3","key":"10.1016\/j.bulcan.2020.11.014_bib0135","first-page":"93","article-title":"Chimeric antigen-receptor T-cell therapy for hematological malignancies and solid tumors: clinical data to date, current limitations and perspectives","volume":"65","author":"Gauthier","year":"2017","journal-title":"Curr Res Transl Med"},{"issue":"2","key":"10.1016\/j.bulcan.2020.11.014_bib0140","first-page":"43","article-title":"Chimeric antigen receptor T cell therapy for non-Hodgkin lymphoma","volume":"66","author":"Ghobadi","year":"2018","journal-title":"Curr Res Transl Med"},{"issue":"2","key":"10.1016\/j.bulcan.2020.11.014_bib0145","first-page":"62","article-title":"Beginning the CAR T cell therapy revolution in the US and EU","volume":"66","author":"Grupp","year":"2018","journal-title":"Curr Res Transl Med"},{"key":"10.1016\/j.bulcan.2020.11.014_bib0150","article-title":"Real world experience of approved chimeric antigen receptor T-cell therapies outside of clinical trials [published online ahead of print, 2020\u00a0Aug 15]","author":"Yassine","year":"2020","journal-title":"Curr Res Transl Med"},{"issue":"19","key":"10.1016\/j.bulcan.2020.11.014_bib0155","doi-asserted-by":"crossref","first-page":"31368","DOI":"10.18632\/oncotarget.15572","article-title":"Retargeting of T lymphocytes to PSCA- or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology \u201cUniCAR\u201d","volume":"8","author":"Feldmann","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.bulcan.2020.11.014_bib0160","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/bjh.13889","article-title":"Chimeric Antigen Receptor (CAR) therapy for multiple myeloma","volume":"172","author":"Atanackovic","year":"2016","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.bulcan.2020.11.014_bib0165","doi-asserted-by":"crossref","first-page":"e1308618","DOI":"10.1080\/2162402X.2017.1308618","article-title":"Novel anti-myeloma immunotherapies targeting the SLAM family of receptors","volume":"6","author":"Radhakrishnan","year":"2017","journal-title":"Oncoimmunology"},{"issue":"3","key":"10.1016\/j.bulcan.2020.11.014_bib0170","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1016\/j.bbmt.2018.12.068","article-title":"Clinical utilization of chimeric antigen receptor T cells in B cell acute lymphoblastic leukemia: an expert opinion from the European Society for Blood and Marrow Transplantation and the American Society for Blood and Marrow Transplantation","volume":"25","author":"Kansagra","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6343","key":"10.1016\/j.bulcan.2020.11.014_bib0175","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1126\/science.356.6343.1112","article-title":"Supply of promising T cell therapy is strained","volume":"356","author":"Couzin-Frankel","year":"2017","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.bulcan.2020.11.014_bib0180","first-page":"111","article-title":"CAR T-cell treatment during the COVID-19\u00a0pandemic: management strategies and challenges","volume":"68","author":"Hu","year":"2020","journal-title":"Curr Res Transl Med"},{"issue":"12S","key":"10.1016\/j.bulcan.2020.11.014_bib0185","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.bulcan.2017.10.017","volume":"104","author":"Yakoub-Agha","year":"2017","journal-title":"Bull Cancer"},{"issue":"5","key":"10.1016\/j.bulcan.2020.11.014_bib0190","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1089\/hum.2017.254","article-title":"CAR T cells in trials: recent achievements and challenges that remain in the production of modified T cells for clinical applications","volume":"29","author":"Kohl","year":"2018","journal-title":"Hum Gene Ther"},{"issue":"5","key":"10.1016\/j.bulcan.2020.11.014_bib0195","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1056\/NEJMoa1709919","article-title":"Long-term follow-up of CD19\u00a0CAR therapy in acute lymphoblastic leukemia","volume":"378","author":"Park","year":"2018","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.bulcan.2020.11.014_bib0200","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/trf.14003","article-title":"Autologous lymphapheresis for the production of chimeric antigen receptor T cells","volume":"57","author":"Allen","year":"2017","journal-title":"Transfusion"},{"issue":"5","key":"10.1016\/j.bulcan.2020.11.014_bib0205","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/trf.14110","article-title":"CAR-T cell manufacturing: time to put it in gear","volume":"57","author":"Bersenev","year":"2017","journal-title":"Transfusion"},{"issue":"6","key":"10.1016\/j.bulcan.2020.11.014_bib0210","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1111\/trf.14094","article-title":"Optimizing autologous nonmobilized mononuclear cell collections for cellular therapy in pediatric patients with high-risk leukemia","volume":"57","author":"Even-Or","year":"2017","journal-title":"Transfusion"},{"issue":"6","key":"10.1016\/j.bulcan.2020.11.014_bib0215","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1111\/trf.14569","article-title":"Lymphocyte apheresis for chimeric antigen receptor T-cell manufacturing in children and young adults with leukemia and neuroblastoma","volume":"58","author":"Ceppi","year":"2018","journal-title":"Transfusion"},{"issue":"S1","key":"10.1016\/j.bulcan.2020.11.014_bib0110","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/voxs.12208","article-title":"New developments in the use of apheresis to collect haematopoietic cells for cell transplantation and cell therapies","volume":"11","author":"Granata","year":"2016","journal-title":"ISBT Science Series"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455121000369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455121000369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T19:33:31Z","timestamp":1757792011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455121000369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0007455121000369"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2020.11.014","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Condition de r\u00e9alisation de la cytaph\u00e9r\u00e8se pour la mise \u00e0 disposition du mat\u00e9riel biologique n\u00e9cessaire \u00e0 la production de CAR T-cells commerciaux\u00a0: avis d\u2019experts propos\u00e9 par la SFGM-TC","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2020.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}